当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2009年
22期
157-158
,共2页
艾迪注射液%化疗%晚期卵巢恶性肿瘤%不良反应
艾迪註射液%化療%晚期卵巢噁性腫瘤%不良反應
애적주사액%화료%만기란소악성종류%불량반응
Aidi injection%chemotherapy%advanced maligmant ovarian tumor%adverse reaction
目的 观察艾迪注射液联合化疗对晚期卵巢恶性肿瘤患者的临床疗效.方法 58例晚期卵巢恶性肿瘤患者随机分为两组.观察组29例,给予艾迪注射液联合化疗药物治疗,对照组29例,单纯应用化疗药物.结果 治疗组有效率为68.97%,高于对照组(41.38%),差异显著性(P<0.05),治疗组生存质量比对照组有明显改善(P<0.05),不良反应发生率明显少于对照组(P<0.05).结论 艾迪注射液联合化疗治疗晚期卵巢恶性肿瘤,较单用方案治疗疗效好,不良反应轻,生活质量改善明显.
目的 觀察艾迪註射液聯閤化療對晚期卵巢噁性腫瘤患者的臨床療效.方法 58例晚期卵巢噁性腫瘤患者隨機分為兩組.觀察組29例,給予艾迪註射液聯閤化療藥物治療,對照組29例,單純應用化療藥物.結果 治療組有效率為68.97%,高于對照組(41.38%),差異顯著性(P<0.05),治療組生存質量比對照組有明顯改善(P<0.05),不良反應髮生率明顯少于對照組(P<0.05).結論 艾迪註射液聯閤化療治療晚期卵巢噁性腫瘤,較單用方案治療療效好,不良反應輕,生活質量改善明顯.
목적 관찰애적주사액연합화료대만기란소악성종류환자적림상료효.방법 58례만기란소악성종류환자수궤분위량조.관찰조29례,급여애적주사액연합화료약물치료,대조조29례,단순응용화료약물.결과 치료조유효솔위68.97%,고우대조조(41.38%),차이현저성(P<0.05),치료조생존질량비대조조유명현개선(P<0.05),불량반응발생솔명현소우대조조(P<0.05).결론 애적주사액연합화료치료만기란소악성종류,교단용방안치료료효호,불량반응경,생활질량개선명현.
Objective To evaluate the therapeutic efficacy of Aidi injection combining with chemotherapy in curing advanced maligment ovarian tumor. Methods Fifty eight patients were randomized into two groups. The treatment group of twenty nine patients were treated with Aidi injection and chemotherapy. The control group of patients treated with chemotherapy only. Results The response rate in the treatment group(68.97%) was higher than that in the comparative group (41.38%)(P<0.05); The improvement of pepticsymptom was better than that in comparative group too(P<0.05).The adverse reaction preseted in the treatment group was greatly less than that in the in the comparative group(P<0.05), conlution Aidi injection combining with chemotherapy could enhance the efficacy, reduce the adverse reaction of chemotberapy in treating advanced maligmant ovarian tumor and could also improve the quality of life.
